CD38 and Miyoshi myopathy: CD38 is a kind of cell surface glycoprotein that shows especially extensive and high expression levels in MM, contributing to the disease’s progression.387,398 Consequently, it has become one of the primary targets for developing anti-MM targeted therapy in recent years.